Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Assembly Biosciences (ASMB) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Assembly Biosciences (ASMB) over the last 10 years, with Q3 2025 value amounting to -$9.2 million.

  • Assembly Biosciences' Profit After Tax rose 433.79% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.5 million, marking a year-over-year increase of 553.13%. This contributed to the annual value of -$40.2 million for FY2024, which is 3438.13% up from last year.
  • Per Assembly Biosciences' latest filing, its Profit After Tax stood at -$9.2 million for Q3 2025, which was up 433.79% from -$10.2 million recorded in Q2 2025.
  • Assembly Biosciences' Profit After Tax's 5-year high stood at -$8.8 million during Q1 2025, with a 5-year trough of -$60.3 million in Q4 2021.
  • Its 4-year average for Profit After Tax is -$17.3 million, with a median of -$11.2 million in 2024.
  • As far as peak fluctuations go, Assembly Biosciences' Profit After Tax crashed by 46145.12% in 2021, and later skyrocketed by 5210.03% in 2024.
  • Assembly Biosciences' Profit After Tax (Quarter) stood at -$60.3 million in 2021, then surged by 81.81% to -$11.0 million in 2023, then grew by 5.72% to -$10.3 million in 2024, then increased by 11.02% to -$9.2 million in 2025.
  • Its Profit After Tax was -$9.2 million in Q3 2025, compared to -$10.2 million in Q2 2025 and -$8.8 million in Q1 2025.